' INTRODUCTION
Critical limb ischemia (CLI) is a widespread disease in China, especially in older people. Although statistics are lacking for the Chinese population, according to epidemiological research of other countries (1), more than 5 million Chinese individuals are estimated to suffer from CLI. Due to long-term chronic ischemia, the end-point for CLI patients is usually amputation. Therefore, a method of identifying CLI patients with a high risk for amputation and performing risk stratification at an early time point is always the focus of clinical practice.
CLI is an atherosclerotic disease that is usually associated with a general inflammatory response. Based on previous studies, C-reactive protein (CRP), platelet aggregation, and the neutrophil to lymphocyte ratio (NLR) have been indicated as effective predictive markers for CLI patients (2) . The NLR has universally been accepted as a predictive index for stent patency (3, 4) , amputation-free survival (AFS) (5) , and mortality (6) (7) (8) . However, these studies usually focus on preoperative or postoperative NLR in CLI patients who have undergone an operation or intervention. Little research has been performed on CLI patients who receive conservative treatment. Furthermore, the NLR has been adopted for prognosis evaluation in various medical fields including hearing loss (9) , peripheral artery disease (PAD) (10, 11) , bladder cancer (12) , prostatic hyperplasia (13), pancreatic cancer (14, 15) , and colorectal cancer (16, 17) .
However, whether the post-treatment NLR (post-NLR) can predict the prognosis in CLI patients is unclear. Therefore, the present study was designed to evaluate the predictive value of the post-NLR in CLI patients who receive conservative therapy.
' METHODS

Patients and methods
The objective inclusion criteria for enrolled patients with a diagnosis of CLI consisted of more than two weeks of foot pain associated with an ankle-brachial index of 0.4 or less, an ankle systolic pressure of 50 mm Hg or less, or a toe systolic pressure of 30 mm Hg or less (Rutherford categories 4 and 5 (18) . Patients with a) decisive evidence of acute limb ischemia; b) clinical symptoms or signs of sepsis, any other inflammation or a white blood cell (WBC) count 410*10 9 /L; c) poor data integrity; d) a previous surgery history; or e) any diseases or drug that would affect the lymphocyte count, such as lymphopenia, lymphemia, acute cardinal infraction and corticosteroid use, were excluded from this study.
In this study, all of the enrolled patients who received conservative therapy were not candidates for revascularization due to poor general condition, loss of indication, severe local infection or patient unwillingness.
At admission, the demographics (age, gender), history (smoking, drug use), comorbidities and results of laboratory tests (in particular, the neutrophil, lymphocyte, and WBC counts) were recorded in a specific database by doctors and nurses. All enrolled patients received the same standardized conservative therapy plan (antiplatelet, anticoagulation and vasodilator drugs were given intravenously for approximately 7 days). The same blood tests were conducted 7 days after admission.
NLR definition
The pre-treatment WBC and differential counts were evaluated at admission before conservative therapy. The post-treatment counts evaluated taken 7 days later after conservative therapy was adopted. The NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count (19) .
Follow-up after discharge
Discharged patients were followed via outpatient consultation or telephone calls. Each patient received the same unified follow-up form and was followed at the end of the 1st, 3rd, 6th, and 12th month after discharge, then annually thereafter. Telephone follow-up was performed at the same intervals. In this study, the primary end-points were amputation [above-the-knee amputation (AKA), below-the-knee amputation (BKA) or Toe] or 36 months after discharge.
Analysis method
Data analysis was performed with SPSS version 16 (SPSS Inc, Chicago, IL). Categorical data and continuous variables were compared with the chi-square test or Fisher's exact test and the independent sample t-test, respectively. The incidence of amputation was analyzed by the Kaplan-Meier method, and the difference was compared with a log-rank test. Independent risk factors were identified by multivariate Cox proportional hazards regression analysis. The calculated P-values were two-sided, and a P-value o0.05 was considered significant.
Ethics
The patients included in this study were recruited from the Vascular Department of West China Hospital, Sichuan University, between January 2009 and January 2011. The study was approved by the Ethics Committee of West China Hospital, Sichuan University.
' RESULTS
Based on the exclusion criteria, 12 patients were excluded from the final analysis due to a) determined evidence of acute limb ischemia (n = 1); b) clinical symptoms or signs of sepsis or any other inflammation or WBC counts 4 10*10 9 /L (n = 6); c) poor data integrity (n = 3); or d) a history of previous surgery (n = 2). A total of 172 patients were included in the final outcome analysis.
Cutoff value of post-NLR identification
The analysis of the relationship between post-NLR and AFS was conducted using tertiles of existing data (e.g., Post-NLR o3.4, Post-NLR 46.8 and Post-NLR between 3.4 and 6.8). This grouping method showed a significant discrimination effect (P = 0.006, Figure 1) .
The post-NLR appeared to have a significant influence on the outcome in a continuous manner. The post-NLR appeared to be negatively correlated with the outcome. An ROC curve was used to identify the cutoff value, which is shown in Figure 2 . In the ROC analysis setting, amputation was set as the state variable. The C-statistic (area under the curve) was 0.740. A post-NLR of 3.8 was selected as the cutoff value because it had the maximum discriminative power (sensitivity 70.2%, specificity 71.7%). Seventy-four patients (43%) had a post-NLR Z3.8, and 98 patients had a post-NLR o3.8.
Baseline characteristics
A total of 172 patients with mean age of 71.98 ± 10.09 years were included, and 70.9% (n = 122) of these patients were male. The mean follow-up duration was 34.7 months (range 3.25 to 62.5 months). The 74 patients with a post-NLR Z3.8 were collectively called group A, and the 98 patients with a post-NLR o3.8 were called group B. The mean ages in groups A and B were 71.83 ± 11.00 and 72.00 ± 9.52, respectively. The baseline characteristic comparison between group A and group B is shown in Table 1 . The incidence of diabetes mellitus, the pre-NLR, the post-NLR, the monocyte count, and the cholesterol level were significantly different between the two groups.
Impact of the post-NLR on amputation
Overall, the AFS rates in group A (post-NLR Z3.8) and group B (post-NLR o3.8) were 43.2% and 82.7%, respectively. Furthermore, the 1-year, 2-year and 3-year incidence rates of AFS in group A were 83.8%, 67.6% and 43.2%, respectively. By contrast, the respective 1-year, 2-year and 3-year AFS rates were 89.8%, 82.7% and 82.7% in group B. Thus, 42 patients suffered from amputation during followup in group A, whereas only 17 patients received amputations in group B (Po0.001). A detailed comparison of amputation instances is shown in Table 2 . Moreover, the survival outcome showed a significant difference between groups A and B (Po0.001), which is shown in Figure 3 .
Independent risk factor identification
Risk factors for CLI patients, including diabetes mellitus, pre-NLR, post-NLR, monocyte albumin and cholesterol level, were included in the multivariate analysis (Cox proportional hazards model). The analysis results showed that the post-NLR and albumin were independent risk factors of amputation ( 
' DISCUSSION
The post-NLR was identified as an independent predictive factor of amputation in CLI patients who did not undergo surgery. CLI patients usually suffer from malnutrition (20) due to sleeplessness and lack of appetite, leading to chronic ischemic pain. Moreover, variable albumin is a crucial index for evaluating a patient's nutritional condition, and hypoproteinemia is a risk factor for amputation in PAD (21, 22) . In this study, albumin was identified as an independent protective factor, which is in accordance with previous studies.
With respect to previous studies, major lower limb amputations (AKA or BKA) at 1 year occur in approximately 20% of untreated CLI patients (23, 24) . In this study, the 1-year amputation rate was 16.2% in group A (post-NLR Z3.8) and 10.2% in group B (post-NLR o3.8). Therefore, no significant difference in the final outcome was observed for untreated CLI patients and patients who received conservative therapy. This result needs to be confirmed by a systematic review or randomized controlled trial in the future. However, this study suggests that CLI patients with a higher post-NLR have a worse prognosis.
A risk-stratification model is an important clinical tool that uses existing clinical data to predict a patient's prognosis and provides a rational discrimination between risky and nonrisky patients. The NLR contains crucial information regarding the patient's inflammatory condition. Moreover, the NLR is different from other inflammation markers. It is an inexpensive and readily available marker that is directly calculated from the neutrophil and lymphocyte counts and can easily be obtained from a complete blood cell test on admission.
Furthermore, CLI is a form of chronic atherosclerosis, and fibrosis progression is associated with the general immuneinflammatory response. Repeated local inflammatory responses involving the neutrophils and lymphocytes lead to fibrosis, which aggravates ischemia. The NLR is an effective systematic inflammatory marker that represents the inflammatory condition. When severe ischemia occurs and infection and immune disease are simultaneously excluded, a systematic increase in the post-NLR could represent an irreversible ischemic condition that may lead to an endpoint event (e.g., amputation). The NLR predicts endpoint events in other medical fields, including myocardial ischemia (25) and severe sepsis (26) .
In this study, all of the enrolled patients underwent conservative therapy; however, compared with all CLI patients over the same period of time, the proportion of patients receiving conservative therapy was still low. Previous studies have shown that revascularization procedures (e.g., surgery and angioplasty/stenting) can produce a better prognosis than conservative therapy (27) (28) (29) . In terms of patients who are suitable candidates for revascularization, surgery, intervention or a hybrid procedure is still the optimal choice.
Although this study is prospective with respect to patient collection and discharge follow-up, selection bias cannot be denied. Nearly all of the enrolled patients used antiplatelet therapy, but only 48 subjects (27.9%) received statins. In addition, the post-NLR could not be compared with other inflammatory markers, such as C-reactive protein or the erythrocyte sedimentation rate, because they are not routine tests performed at admission. Moreover, isolated patients with anemia and a hemoglobin level of less than 70 g/L received transfusion therapy. This confounding factor was not included in the analysis in this study.
The post-NLR is an effective marker for amputation in CLI patients who do not undergo an operation. When the post-NLR Z3.8, CLI patients are more likely to suffer from amputation compared with patients with a post-NLR o3.8. To avoid amputation and increase AFS, revascularization procedures are still the optimal choice. 
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